SF Healthcare Week: Roivant CEO Matt Gline provides an update on the 'vant ecosystem

blonca9
Jan 13
1 min read

He discusses key data in the year ahead including from Immunovant and Priovant. Plus, an update on the lawsuits regarding covid vaccine LNP delivery IP and how he thinks about Roivant's cash balance.

Recent Posts

See All

VERAXA Biotech, which is part of Switzerland's Xlife Sciences incubator, will be going public in the U.S. via a SPAC in Q4 of this year. The company uses an AND-gating technology for TCEs and ADCs

Zurich based CUTISS is developing a personalized tissue therapy that enables on-demand production of living skin for surgeries

Creyon Bio today announced a collaboration to help Lilly use its AI-powered oligo engineering platform and aptamer-based delivery approach to discover and develop therapies in a range of diseases

SF Healthcare Week: Roivant CEO Matt Gline provides an update on the 'vant ecosystem

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight